Personal use of postmenopausal hormone replacement therapy by women physicians in the United States

Annals of Internal Medicine

Volumn 127, Issue 12, 1997, Pages 1093-1096

  McNagny, Sally E ^a   Wenger, Nanette Kass ^a   Frank, Erica ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; HYSTERECTOMY; NORMAL HUMAN; PHYSICIAN; PHYSICIAN ATTITUDE; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031453057     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-12-199712150-00007     Document Type: Article

References (20)

1. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol. 1995;85:6-10.
2. Hemminki E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogens among middle-aged Massachusetts women. Ann Pharmacother. 1991;25: 418-23.
3. Pilote L, Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease [Editorial]. Am Heart J. 1995;129:1237-8.
4. Falik M, Collins K. Women's Health: The Commonwealth Fund Survey. Baltimore: Johns Hopkins Univ Pr; 1996.
5. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med. 1990;5:464-9.
6. Frank E. The Women Physicians' Health Study: background, objectives, and methods. J Am Med Wom Assoc. 1995;50:64-6.
7. Frank E, Brogan DJ, Mokdad AD, Simoes EJ, Kahn HS, Greenberg RS. Health-related behaviors of U.S. women physicians versus other U.S. women. Arch Intern Med. [In press].
8. Frank E, Rothenberg R, Brown WV, Maibach H. Basic demographic and professional characteristics of US women physicians. West J Med. 1997;166: 179-84.
9. Frank E, Schiffman M. Harassment experiences of U.S. women physicians. Arch intern Med. [In press].
10. Barrett-Connor E. Prevalence, initiation, and continuation of hormone replacement therapy. Journal of Women's Health. 1995;4:143-8.
11. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438-44.
12. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc. 1996;44:1-6.
13. SUDAAN User's Manual. Version 6.4. Durham, NC: Research Triangle Institute; 1996.
14. Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ. 1995;311:1399-401.
15. Oddens BJ, Boulet MJ, Lehert P, Visser AP. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries. Maturitas. 1992;15:171-81.
16. Nelson DE, Giovino GA, Emont SL, Brackbill R, Cameron LL, Peddicord J, et al. Trends in cigarette smoking among US physicians and nurses. JAMA. 1994;271:1273-5.
17. Frank E, Kunovich-Frieze T. Physicians' prevention counseling behaviors: current status and future directions. Prev Med. 1995;24:543-5.
18. Grisso JA, Baum CR, Turner BJ. What do physicians in practice do to prevent osteoporosis? J Bone Miner Res. 1990;5:213-9.
19. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Hormone replacement therapy. ACOG Technical Bulletin. 1992;166:1-8.
20. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-7.